Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,500
Closed -$330K 3430
2021
Q4
$330K Buy
18,500
+1,600
+9% +$30.7K ﹤0.01% 3573
2021
Q3
$321K Sell
16,900
-2,000
-11% -$33.2K ﹤0.01% 3616
2021
Q2
$406K Buy
+18,900
New +$407K ﹤0.01% 3269
2021
Q1
Sell
-17,900
Closed -$323K 4016
2020
Q4
$323K Buy
+17,900
New +$247K ﹤0.01% 2802
2017
Q4
Sell
-10,800
Closed -$245K 3249
2017
Q3
$245K Buy
+10,800
New +$223K ﹤0.01% 2517
2016
Q4
Sell
-12,000
Closed -$348K 3295
2016
Q3
$348K Buy
+12,000
New +$366K ﹤0.01% 2659

Other funds holding IMAX

John Overdeck's IMAX Position: Q2 2026 in Review

John Overdeck reduced its IMAX (IMAX) stake by 59% in Q2 2026, selling an estimated $15.7M and leaving 281,421 shares worth $11.2M. The position accounts for 0.01% of the portfolio, ranked #1449.

John Overdeck first reported a position in IMAX in Q4 2014 and has held it in 43 quarters since. The position peaked at $26.3M in Q1 2026. 255 funds tracked by Wall St. Rank hold IMAX as of Q2 2026.

  • John Overdeck held 281,421 shares of IMAX worth $11.2M as of Q2 2026.
  • John Overdeck sold 410,053 IMAX shares in Q2 2026, an estimated $15.7M.
  • IMAX made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1449 holding.
  • John Overdeck first reported a position in IMAX in Q4 2014 and has held it in 43 quarters since.
  • John Overdeck's IMAX position peaked at $26.3M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held IMAX as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.